Text Size

Functional Neuroimaging Effects of Cognitive Remediation Training

This study has been completed.
Sponsor:
Collaborator:
Minnesota Medical Foundation
Information provided by:
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT00481156
First received: May 30, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
  Purpose

The purpose of this study is to examine behavioral and functional brain changes occuring as a result of cognitive remediation training in patients with schizophrenia. Extension and specificity of related changes will also be examined.


Condition Intervention
Schizophrenia
 Behavioral: Cognitive Remediation
Behavioral: Cognitive Behavioral Social Skills Training

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Treatment

Resource links provided by NLM:

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources

Further study details as provided by University of Minnesota - Clinical and Translational Science Institute:

Primary Outcome Measures:
  • Working Memory performance
  • Brain activation

Estimated Enrollment: 18
Study Start Date: September 2005
  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Diagnosis of schizophrenia or schizoaffective disorder
  • Stable outpatient

Exclusion Criteria:

  • Current drug abuse or dependence
  • History of neurological damage, disorder, or disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00481156

Locations
United States, Minnesota
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Sponsors and Collaborators
University of Minnesota - Clinical and Translational Science Institute
Minnesota Medical Foundation
Investigators
Principal Investigator: Angus W MacDonald, Ph.D. University of Minnesota - Clinical and Translational Science Institute
Principal Investigator: Kelvin O Lim, Ph.D. University of Minnesota - Clinical and Translational Science Institute
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00481156     History of Changes
Other Study ID Numbers: 0404M58647, CogRehab
Study First Received: May 30, 2007
Last Updated: May 30, 2007
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on May 23, 2013